Description

Pulmicort Suspension for Inhalation 0.25 mg/ml. 2 ml. №20

Ingredients

Active ingredient: Budesonide. Inactive ingredients: Disodium edetate, sodium chloride, hydrochloric acid, and purified water.

Dosage

Dosage: The usual dose is 0.5 to 1 mg twice daily. The maximum daily dose should not exceed 2 mg twice daily.

Indications

Indications: Pulmicort is indicated for the maintenance treatment of asthma as prophylactic therapy in adults and children.

Contraindications

Contraindications: Do not use Pulmicort in patients with known hypersensitivity to budesonide or any of the ingredients.

Directions

Directions: Administer by inhalation using a suitable nebulizer. Rinse mouth with water after each use to prevent oral fungal infections.

Scientific Evidence

Scientific evidence: Studies have shown that budesonide, the active ingredient in Pulmicort, effectively reduces airway inflammation and improves lung function in asthma patients (Source: Global Initiative for Asthma).

Additional Information

Storage: Store at room temperature away from moisture and heat. Do not freeze. Once opened, use within 2 weeks.

Pharmacological Effects: Budesonide, a corticosteroid, exerts its anti-inflammatory action by inhibiting the release of inflammatory mediators and reducing the infiltration of inflammatory cells in the airways. This helps to decrease airway hyperresponsiveness and improve asthma symptoms.

Clinical Trials: Clinical trials have demonstrated the efficacy of Pulmicort in reducing asthma exacerbations, improving lung function, and enhancing quality of life in patients with persistent asthma. In a randomized controlled trial published in the Journal of Allergy and Clinical Immunology, Pulmicort was found to significantly reduce the rate of severe asthma exacerbations compared to placebo.